Regulators struggle to keep up with the fast-moving and complicated landscape of AI therapy apps

ABC NewsMonday, September 29, 2025 at 4:22:27 AM
NeutralHealth
Regulators struggle to keep up with the fast-moving and complicated landscape of AI therapy apps
As the use of AI-driven mental health chatbots continues to grow, regulators in a few states are finding it challenging to keep pace with the rapid development of these technologies. This situation is significant because it highlights the need for effective oversight to ensure user safety and the efficacy of these emerging therapy apps, which could play a crucial role in mental health support.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Latest from Health
Regulators struggle to keep up with the fast-moving and complicated landscape of AI therapy apps
NeutralHealth
As the use of AI-driven mental health chatbots grows, regulators in a few states are finding it challenging to keep pace with the rapid development of these technologies. This situation is significant because it highlights the need for effective oversight to ensure that these tools are safe and beneficial for users, especially as they become more integrated into mental health care.
58M pounds of corn dogs, sausages-on-a-stick recalled for possible wood pieces
NegativeHealth
A massive recall of 58 million pounds of corn dogs and sausages-on-a-stick has been issued due to potential contamination with wood pieces. This alarming situation has already led to several reported injuries among consumers, raising serious concerns about food safety standards. It's crucial for consumers to stay informed and check their products to avoid any health risks.
Gaza: An American nurse films hospital destruction
NegativeHealth
An American nurse named Vaughan has returned from Gaza City, where she documented the devastating impact of the ongoing conflict on the local healthcare system. As Israeli troops advance, hospitals are facing severe destruction and are on the brink of collapse. Vaughan, who volunteered with the Palestinian Australian New Zealand Medical Association, shared her experiences through a video diary, providing a firsthand look at the dire situation. This matters because it highlights the urgent humanitarian crisis in Gaza and the challenges faced by healthcare workers in conflict zones.
An American nurse in Gaza City films a hospital's collapse as Israeli forces surround it
NegativeHealth
In Gaza City, the health care system is on the brink of collapse as Israeli forces intensify their ground offensive. An American nurse named Vaughan, who has been volunteering with the Palestinian Australian New Zealand Medical Association, filmed the destruction of hospitals and clinics, highlighting the dire situation. With essential supplies running low and facilities shutting down, this crisis underscores the urgent need for humanitarian aid and international attention to the plight of those affected.
Before Trump touted the drug leucovorin for autism, these families had already tried it
NeutralHealth
In a recent press conference, President Donald Trump brought attention to the drug leucovorin in relation to autism, but many families had already explored its use prior to his comments. This highlights the ongoing search for effective treatments for autism and the impact of public figures on health discussions. The conversation around leucovorin may influence perceptions and decisions among families seeking solutions.
President Trump is threatening U.S. pharmaceutical companies with tariffs of 100% to push them to bring manufacturing home, but it may not be so easy to dislodge companies from places like the Irish village of Ringaskiddy
NegativeHealth
President Trump's recent threat to impose 100% tariffs on pharmaceutical companies not manufacturing in the U.S. raises significant concerns. While the intention is to encourage companies to bring jobs back home, the reality is that many firms have established operations in places like Ringaskiddy, Ireland, for various reasons, including cost and logistics. This move could lead to increased drug prices and supply chain disruptions, affecting consumers and the healthcare system.